Search research articles
Contact Us
Filters
Showing results (111-120 of 349) with videos related to
Page
of 35
Sort By:
Journal of Neural Transmission. Supplementum
|
January 1, 1997
Mechanism of 6-hydroxydopamine neurotoxicity
Y Glinka, M Gassen, M B Youdim
Nature
|
July 26, 1974
A phenylethylamine oxidising defect in migraine
M Sandler, M B Youdim, E Hanington
British Journal of Pharmacology
|
June 1, 1975
Proceedings: Substrate and strain-dependent differences in the development of monoamine oxidase in the rat brain
D Blatchford, M Holzbauer, M B Youdim
Pharmacological Research Communications
|
June 1, 1976
Influence of thyroidectomy and compensatory treatment with L-thyroxine upon tissue glycogen stores during last part of pregnancy in the rat
S Parvez, M B Youdim, H Parvez
Journal of Neurology
|
September 19, 2000
MPTP and 6-hydroxydopamine-induced neurodegeneration as models for Parkinson's disease: neuroprotective strategies
E Grünblatt, S Mandel, M B Youdim
The Journal of Clinical Endocrinology and Metabolism
|
March 17, 2000
Clinical review 112: Does serum growth hormone (GH) binding protein reflect human GH receptor function?
T Amit, M B Youdim, Z Hochberg
Communications in Psychopharmacology
|
January 1, 1980
Deprenyl does not cause insomnia in parkinsonian patients
P Lavie, J Wajsbort, M B Youdim
Clinical Neuropharmacology
|
January 1, 1982
(-)Deprenyl in the treatment of Parkinson's disease
W Birkmayer, P Riederer, M B Youdim
Methods in Molecular Medicine
|
February 15, 2011
Oxidative stress indices in Parkinson's disease : biochemical determination
M B Youdim, N Drigues, S Mandel
Advances in Pharmacology (San Diego, Calif.)
|
November 5, 1997
Apomorphine is a potent radical scavenger and protects cultured pheochromocytoma cells from 6-OHDA and H2O2-induced cell death
M Gassen, B Pinchasi, M B Youdim
Page
of 35
Search research articles
Search
Showing results (111-120 of 349) with videos related to
Sort By:
Page
of 35
Journal of Neural Transmission. Supplementum
|
January 1, 1997
Mechanism of 6-hydroxydopamine neurotoxicity
Y Glinka, M Gassen, M B Youdim
Nature
|
July 26, 1974
A phenylethylamine oxidising defect in migraine
M Sandler, M B Youdim, E Hanington
British Journal of Pharmacology
|
June 1, 1975
Proceedings: Substrate and strain-dependent differences in the development of monoamine oxidase in the rat brain
D Blatchford, M Holzbauer, M B Youdim
Pharmacological Research Communications
|
June 1, 1976
Influence of thyroidectomy and compensatory treatment with L-thyroxine upon tissue glycogen stores during last part of pregnancy in the rat
S Parvez, M B Youdim, H Parvez
Journal of Neurology
|
September 19, 2000
MPTP and 6-hydroxydopamine-induced neurodegeneration as models for Parkinson's disease: neuroprotective strategies
E Grünblatt, S Mandel, M B Youdim
The Journal of Clinical Endocrinology and Metabolism
|
March 17, 2000
Clinical review 112: Does serum growth hormone (GH) binding protein reflect human GH receptor function?
T Amit, M B Youdim, Z Hochberg
Communications in Psychopharmacology
|
January 1, 1980
Deprenyl does not cause insomnia in parkinsonian patients
P Lavie, J Wajsbort, M B Youdim
Clinical Neuropharmacology
|
January 1, 1982
(-)Deprenyl in the treatment of Parkinson's disease
W Birkmayer, P Riederer, M B Youdim
Methods in Molecular Medicine
|
February 15, 2011
Oxidative stress indices in Parkinson's disease : biochemical determination
M B Youdim, N Drigues, S Mandel
Advances in Pharmacology (San Diego, Calif.)
|
November 5, 1997
Apomorphine is a potent radical scavenger and protects cultured pheochromocytoma cells from 6-OHDA and H2O2-induced cell death
M Gassen, B Pinchasi, M B Youdim
Page
of 35